BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed ARWR catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:0ce3dc1bbe6fbbe6f019@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270201
DTEND;VALUE=DATE:20270202
SUMMARY:ARWR P1/P2 readout (est.): A First-In-Human Study of ARO-ALK7 in Ad
 ults With Obesity With and Without Type 2 Diabetes Mellitus
DESCRIPTION:A First-In-Human Study of ARO-ALK7 in Adults With Obesity With 
 and Without Type 2 Diabetes Mellitus\nNCT06937203 | PHASE1/PHASE2 | RECRUI
 TING | sponsor: Arrowhead Pharmaceuticals\nPrimary completion date (ESTIMA
 TED)\; top-line results usually follow later.\nDate precision: month (show
 n on the first day)\nTicker ARWR (confidence 0.9)\nSource: https://clinica
 ltrials.gov/study/NCT06937203\nScheduling/reference data from public recor
 ds\; dates can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06937203
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
